Assembly Biosciences, Inc. Adjustments to Additional Paid in Capital, Other
Assembly Biosciences, Inc. (ASMB) reported Adjustments to Additional Paid in Capital, Other of $904 for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-14.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2014-05-14
- Assembly Biosciences, Inc. adjustments to additional paid in capital, other for the quarter ending 2014-03-31 was $904.00, a 94.55% decline year-over-year.
- Assembly Biosciences, Inc. adjustments to additional paid in capital, other for the quarter ending 2013-12-31 was $6.84K.
- Assembly Biosciences, Inc. adjustments to additional paid in capital, other for the quarter ending 2013-09-30 was $7.13K, a 79.02% decline year-over-year.
- Assembly Biosciences, Inc. adjustments to additional paid in capital, other for the quarter ending 2013-06-30 was $5.62K, a 91.60% decline year-over-year.
- Assembly Biosciences, Inc. adjustments to additional paid in capital, other for fiscal 2013 was $36.16K.
- Assembly Biosciences, Inc. adjustments to additional paid in capital, other for fiscal 2011 was $3.99M.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 6 month | Adjustments to Additional Paid in Capital, Other 9 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|---|---|
| 2014-03-31 | $904.00 10-Q · filed 2014-05-14 | $7.75K derived: sum of 2 quarters · filed 2014-05-14 | $14.87K derived: sum of 3 quarters · filed 2014-05-14 | $20.49K derived: sum of 4 quarters · filed 2014-05-14 |
| 2013-12-31 | $6.84K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $13.97K derived: sum of 2 quarters · filed 2014-03-31 | $19.58K derived: sum of 3 quarters · filed 2014-03-31 | $36.16K 10-K · filed 2014-03-31 |
| 2013-09-30 | $7.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $12.74K derived: sum of 2 quarters · filed 2013-11-12 | $29.32K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $5.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $22.19K 10-Q · filed 2013-08-09 | ||
| 2013-03-31 | $16.57K 10-Q · filed 2013-05-10 | |||
| 2012-09-30 | $33.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | $100.80K derived: sum of 2 quarters · filed 2012-11-13 | $326.31K 10-Q · filed 2012-11-13 | $684.73K derived: sum of 4 quarters · filed 2014-03-31 |
| 2012-06-30 | $66.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $292.35K 10-Q · filed 2012-08-09 | $650.77K derived: sum of 3 quarters · filed 2014-03-31 | $1.04M derived: sum of 4 quarters · filed 2014-03-31 |
| 2012-03-31 | $225.51K 10-Q · filed 2012-05-09 | $583.93K derived: sum of 2 quarters · filed 2014-03-31 | $975.37K derived: sum of 3 quarters · filed 2014-03-31 | |
| 2011-12-31 | $358.42K derived: 10-K 12 month − 10-Q/A 9 month · filed 2014-03-31 | $749.85K derived: sum of 2 quarters · filed 2014-03-31 | $3.99M 10-K · filed 2014-03-31 | |
| 2011-09-30 | $391.43K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2011-11-18 | $3.63M 10-Q/A · filed 2011-11-18 | ||
| 2011-06-30 | $3.24M 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |